1. Home
  2. WALD vs TNXP Comparison

WALD vs TNXP Comparison

Compare WALD & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.86

Market Cap

179.6M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.35

Market Cap

169.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WALD
TNXP
Founded
1988
2007
Country
United Kingdom
United States
Employees
364
142
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.6M
169.8M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
WALD
TNXP
Price
$1.86
$11.35
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
605.0K
522.0K
Earning Date
03-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$9.89
$558.11
Revenue Next Year
$4.31
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$0.72
$10.03
52 Week High
$3.22
$69.65

Technical Indicators

Market Signals
Indicator
WALD
TNXP
Relative Strength Index (RSI) 64.24 41.50
Support Level $1.77 N/A
Resistance Level $2.03 $14.85
Average True Range (ATR) 0.20 0.91
MACD 0.02 -0.13
Stochastic Oscillator 85.44 32.77

Price Performance

Historical Comparison
WALD
TNXP

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: